Abásolo, D., Hornero, R., Gómez, C., García, M., López, M., Analysis of EEG background activity in Alzheimer's disease patients with Lempel-Ziv complexity and central tendency measure. Med Eng Phys 28 (2006), 315–322, 10.1016/j.medengphy.2005.07.004.
Adamska, I., Finc, K., Effect of LSD and music on the time-varying brain dynamics. Psychopharmacology (Berl) 240 (2023), 1601–1614, 10.1007/s00213-023-06394-8.
Aleksandrova, L.R., Phillips, A.G., Neuroplasticity as a convergent mechanism of ketamine and classical psychedelics. Trends Pharmacol. Sci. 42 (2021), 929–942, 10.1016/j.tips.2021.08.003.
Alnagger NLN, Cardone P, Martial C, Perl YS, Mindlin I, Sitt JD, et al. A virtual clinical trial of psychedelics to treat patients with disorders of consciousness 2024:2024.08.16.608251. https://doi.org/10.1101/2024.08.16.608251.
Annen, J., Frasso, G., van der Lande, G.J.M., Bonin, E.A.C., Vitello, M.M., Panda, R., et al. Cerebral electrometabolic coupling in disordered and normal states of consciousness. Cell Rep, 42, 2023, 112854, 10.1016/j.celrep.2023.112854.
Arena, A., Comolatti, R., Thon, S., Casali, A.G., Storm, J.F., General anesthesia disrupts complex cortical dynamics in response to intracranial electrical stimulation in rats. eNeuro, 8(4), 2021, ENEURO.0343-20.2021, 10.1523/ENEURO.0343-20.2021.
Arena, A., Juel, B.E., Comolatti, R., Thon, S., Storm, J.F., Capacity for consciousness under ketamine anaesthesia is selectively associated with activity in posteromedial cortex in rats. Neurosci. Conscious. 2022 (2022), 1–15, 10.1093/nc/niac004.
Arzi, A., Rozenkrantz, L., Gorodisky, L., Rozenkrantz, D., Holtzman, Y., Ravia, A., et al. Olfactory sniffing signals consciousness in unresponsive patients with brain injuries. Nature 581 (2020), 428–433, 10.1038/s41586-020-2245-5.
Aubinet, C., Cassol, H., Bodart, O., Sanz, L.R.D., Wannez, S., Martial, C., et al. Simplified Evaluation of CONsciousness Disorders (SECONDs) in individuals with severe brain injury: a validation study. Ann. Phys. Rehabil. Med., 2020, 10.1016/j.rehab.2020.09.001.
Barrett, F.S., Robbins, H., Smooke, D., Brown, J.L., Griffiths, R.R., Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions. Front Psychol, 8, 2017, 10.3389/fpsyg.2017.01238.
Barrett, F.S., Preller, K.H., Kaelen, M., Psychedelics and music: neuroscience and therapeutic implications. Int Rev Psychiatry 30 (2018), 350–362, 10.1080/09540261.2018.1484342.
Brookes, M.J., Woolrich, M.W., Barnes, G.R., Measuring functional connectivity in MEG: a multivariate approach insensitive to linear source leakage. Neuroimage 63 (2012), 910–920, 10.1016/j.neuroimage.2012.03.048.
Bruña, R., Maestú, F., Pereda, E., Phase locking value revisited: teaching new tricks to an old dog. J Neural Eng, 15, 2018, 056011, 10.1088/1741-2552/aacfe4.
Cameron, L.P., Tombari, R.J., Lu, J., Pell, A.J., Hurley, Z.Q., Ehinger, Y., et al. A non-hallucinogenic psychedelic analogue with therapeutic potential. Nature 589 (2021), 474–479, 10.1038/s41586-020-3008-z.
Cardone, P., Alnagger, N., Annen, J., Bicego, A., Gosseries, O., Martial, C., Psychedelics and disorders of consciousness: the current landscape and the path forward. Neurosci. Conscious., 2024, 2024, niae025, 10.1093/nc/niae025.
Cardone, P., Bonhomme, A., Bonhomme, V., Lejeune, N., Staquet, C., Defresne, A., Alnagger, N., Ezan, P., Lee, M., Piarulli, A., Goethem, S., Montupil, J., Thibaut, A., Martial, C., Gosseries, O., A pilot human study using ketamine to treat disorders of consciousness. iScience, 28(1), 2025, 111639, 10.1016/j.isci.2024.111639.
Carhart-Harris, R.L., Bolstridge, M., Rucker, J., Day, C.M.J., Erritzoe, D., Kaelen, M., et al. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Lancet Psychiatry 3 (2016), 619–627, 10.1016/S2215-0366(16)30065-7.
Carhart-Harris, R., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., et al. Trial of Psilocybin versus Escitalopram for Depression. N. Engl. J. Med. 384 (2021), 1402–1411, 10.1056/nejmoa2032994.
Casali, A.G., Gosseries, O., Rosanova, M., Boly, M., Sarasso, S., Casali, K.R., et al. A theoretically based index of consciousness independent of sensory processing and behavior. Sci. Transl. Med., 5, 2013, 10.1126/scitranslmed.3006294.
Casarotto, S., Comanducci, A., Rosanova, M., Sarasso, S., Fecchio, M., Napolitani, M., et al. Stratification of unresponsive patients by an independently validated index of brain complexity. Ann. Neurol. 80 (2016), 1–28, 10.1002/eji.201445427.This.
Chatelle, C., Majerus, S., Whyte, J., Laureys, S., Schnakers, C., A sensitive scale to assess nociceptive pain in patients with disorders of consciousness. J. Neurol. Neurosurg. Psychiatry 83 (2012), 1233–1237, 10.1136/jnnp-2012-302987.
Colclough, G.L., Woolrich, M.W., Tewarie, P.K., Brookes, M.J., Quinn, A.J., Smith, S.M., How reliable are MEG resting-state connectivity metrics?. Neuroimage 138 (2016), 284–293, 10.1016/j.neuroimage.2016.05.070.
Danforth, A.L., Grob, C.S., Struble, C., Feduccia, A.A., Walker, N., Jerome, L., et al. Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study. Psychopharmacology 235 (2018), 3137–3148, 10.1007/S00213-018-5010-9/TABLES/5.
Edlow, B.L., Sanz, L.R.D., Polizzotto, L., Pouratian, N., Rolston, J.D., Snider, S.B., et al. Therapies to Restore Consciousness in Patients with Severe Brain Injuries: A Gap Analysis and Future Directions. Neurocrit. Care 35 (2021), 68–85, 10.1007/s12028-021-01227-y.
Farnes, N., Juel, B.E., Nilsen, A.S., Romundstad, L.G., Storm, J.F., Increased signal diversity/complexity of spontaneous EEG, but not evoked EEG responses, in ketamine-induced psychedelic state in humans. PLoS One, 15, 2020, e0242056, 10.1371/journal.pone.0242056.
Giacino, J.T., Ashwal, S., Childs, N., Cranford, R., Jennett, B., Katz, D.I., et al. The Minimally Conscious State. Neurological Review 64 (2002), 350–351, 10.1001/archneur.64.10.1400.
Giacino, J.T., Kalmar, K., Whyte, J., The JFK Coma Recovery Scale-Revised: Measurement characteristics and diagnostic utility. Arch. Phys. Med. Rehabil. 85 (2004), 2020–2029, 10.1016/j.apmr.2004.02.033.
Goel, A., Rai, Y., Sivadas, S., Diep, C., Clarke, H., Shanthanna, H., et al. Use of Psychedelics for Pain: A Scoping Review. Anesthesiology 139 (2023), 523–536, 10.1097/ALN.0000000000004673.
Goodwin, G.M., Aaronson, S.T., Alvarez, O., Arden, P.C., Baker, A., Bennett, J.C., et al. Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. N Engl J Med 387 (2022), 1637–1648, 10.1056/NEJMoa2206443.
Gosseries, O., Martial, C., The use of psychedelics in the treatment of disorders of consciousness. Alius Bulletin, 2020.
Griffiths, R.R., Johnson, M.W., Carducci, M.A., Umbricht, A., Richards, W.A., Richards, B.D., et al. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology (Oxford, England), 30, 2016, 1181, 10.1177/0269881116675513.
Hasler, F., Bourquin, D., Brenneisen, R., Bär, T., Vollenweider, F.X., Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man. Pharm. Acta Helv. 72 (1997), 175–184, 10.1016/S0031-6865(97)00014-9.
Hasler, F., Grimberg, U., Benz, M.A., Huber, T., Vollenweider, F.X., Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study. Psychopharmacology 172 (2004), 145–156, 10.1007/s00213-003-1640-6.
Jobst, B.M., Atasoy, S., Ponce-Alvarez, A., Sanjuán, A., Roseman, L., Kaelen, M., et al. Increased sensitivity to strong perturbations in a whole-brain model of LSD. Neuroimage, 230, 2021, 117809, 10.1016/j.neuroimage.2021.117809.
Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orban, C., Lorenz, R., et al. LSD modulates music-induced imagery via changes in parahippocampal connectivity. Eur Neuropsychopharmacol 26 (2016), 1099–1109, 10.1016/j.euroneuro.2016.03.018.
Kometer, M., Pokorny, T., Seifritz, E., Volleinweider, F.X., Psilocybin-induced spiritual experiences and insightfulness are associated with synchronization of neuronal oscillations. Psychopharmacology 232 (2015), 3663–3676, 10.1007/s00213-015-4026-7.
Krystal, J.H., Abdallah, C.G., Sanacora, G., Charney, D.S., Duman, R.S., Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron 101 (2019), 774–778, 10.1016/J.NEURON.2019.02.005.
Laureys, S., Celesia, G.G., Cohadon, F., Lavrijsen, J., León-Carrión, J., Sannita, W.G., et al. Unresponsive wakefulness syndrome: A new name for the vegetative state or apallic syndrome. BMC Med. 8 (2010), 2–5, 10.1186/1741-7015-8-68.
Lempel, A., Ziv, J., On the Complexity of Finite Sequences. IEEE Trans Inform Theory 22 (1976), 75–81, 10.1109/TIT.1976.1055501.
Lewis, V., Bonniwell, E.M., Lanham, J.K., Ghaffari, A., Sheshbaradaran, H., Cao, A.B., et al. A non-hallucinogenic LSD analog with therapeutic potential for mood disorders. Cell Rep., 42, 2023, 10.1016/J.CELREP.2023.112203.
Li, D., Vlisides, P.E., Mashour, G.A., Dynamic reconfiguration of frequency-specific cortical coactivation patterns during psychedelic and anesthetized states induced by ketamine. Neuroimage, 249, 2022, 118891, 10.1016/j.neuroimage.2022.118891.
Liu, Z., Fukunaga, M., de Zwart, J.A., Duyn, J.H., Large-Scale Spontaneous Fluctuations and Correlations in Brain Electrical Activity Observed with Magnetoencephalography. Neuroimage 51 (2010), 102–111, 10.1016/j.neuroimage.2010.01.092.
Lu, J., Tjia, M., Mullen, B., Cao, B., Lukasiewicz, K., Shah-Morales, S., et al. An analog of psychedelics restores functional neural circuits disrupted by unpredictable stress. Mol. Psychiatry 2021 (2021), 1–16, 10.1038/s41380-021-01159-1.
MacCallum, C.A., Lo, L.A., Pistawka, C.A., Deol, J.K., Therapeutic use of psilocybin: Practical considerations for dosing and administration. Front Psychiatry, 13, 2022, 1040217, 10.3389/fpsyt.2022.1040217.
Magliacano, A., Rosenfelder, M., Hieber, N., Bender, A., Estraneo, A., Trojano, L., Spontaneous eye blinking as a diagnostic marker in prolonged disorders of consciousness. Sci Rep, 11, 2021, 22393, 10.1038/s41598-021-01858-3.
Mat, B., Sanz, L.R.D., Arzi, A., Boly, M., Laureys, S., Gosseries, O., New Behavioral Signs of Consciousness in Patients with Severe Brain Injuries. Semin Neurol 42 (2022), 259–272, 10.1055/a-1883-0861.
Medel, V., Irani, M., Crossley, N., Ossandón, T., Boncompte, G., Complexity and 1/f slope jointly reflect brain states. Sci Rep, 13, 2023, 21700, 10.1038/s41598-023-47316-0.
Mediano, P.A.M., Rosas, F.E., Timmermann, C., Roseman, L., Nutt, D.J., Feilding, A., et al. Effects of External Stimulation on Psychedelic State Neurodynamics. ACS Chem Neurosci 15 (2024), 462–471, 10.1021/acschemneuro.3c00289.
Mitchell, J.M., Bogenschutz, M., Lilienstein, A., Harrison, C., Kleiman, S., Parker-Guilbert, K., et al. MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study. Nat. Med. 27 (2021), 1025–1033, 10.1038/S41591-021-01336-3.
Muthukumaraswamy, S.D., Carhart-Harris, R.L., Moran, R.J., Brookes, M.J., Williams, T.M., Errtizoe, D., et al. Broadband cortical desynchronization underlies the human psychedelic state. J Neurosci 33 (2013), 15171–15183, 10.1523/JNEUROSCI.2063-13.2013.
Núñez, P., Poza, J., Bachiller, A., Gomez-Pilar, J., Lubeiro, A., Molina, V., et al. Exploring non-stationarity patterns in schizophrenia: neural reorganization abnormalities in the alpha band. J Neural Eng, 14, 2017, 046001, 10.1088/1741-2552/aa6e05.
Nutt, D.J., King, L.A., Phillips, L.D., Drug harms in the UK: A multicriteria decision analysis. Lancet 376 (2010), 1558–1565, 10.1016/S0140-6736(10)61462-6.
Ort, A., Smallridge, J.W., Sarasso, S., Casarotto, S., von Rotz, R., Casanova, A., et al. TMS-EEG and resting-state EEG applied to Altered States of Consciousness: Oscillations. Complexity, and Phenomenology. iScience, 2023, 106589, 10.1016/J.ISCI.2023.106589.
Pal, D., Dean, J.G., Liu, T., Li, D., Watson, C.J., Hudetz, A.G., et al. Differential Role of Prefrontal and Parietal Cortices in Controlling Level of Consciousness. Curr Biol 28 (2018), 2145–2152.e5, 10.1016/j.cub.2018.05.025.
Pal, D., Li, D., Dean, J.G., Brito, M.A., Liu, T., Fryzel, A.M., et al. Level of Consciousness Is Dissociable from Electroencephalographic Measures of Cortical Connectivity, Slow Oscillations, and Complexity. J Neurosci 40 (2020), 605–618, 10.1523/JNEUROSCI.1910-19.2019.
Peterson, A., Tagliazucchi, E., Weijer, C., The ethics of psychedelic research in disorders of consciousness. Neurosci. Conscious. 2019 (2019), 1–8, 10.1093/nc/niz013.
Provencio, J.J., Hemphill, J.C., Claassen, J., Edlow, B.L., Helbok, R., Vespa, P.M., et al. The Curing Coma Campaign: Framing Initial Scientific Challenges—Proceedings of the First Curing Coma Campaign Scientific Advisory Council Meeting. Neurocrit. Care 33 (2020), 1–12, 10.1007/s12028-020-01028-9.
Raison, C.L., Sanacora, G., Woolley, J., Heinzerling, K., Dunlop, B.W., Brown, R.T., et al. Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial. JAMA 330 (2023), 843–853, 10.1001/jama.2023.14530.
Rankaduwa, S., Psychedelics, O.AM., entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives. Neurosci. Conscious., 2023, 2023, 10.1093/NC/NIAD001.
Roach, B.J., Mathalon, D.H., Event-Related EEG Time-Frequency Analysis: An Overview of Measures and An Analysis of Early Gamma Band Phase Locking in Schizophrenia. Schizophr Bull 34 (2008), 907–926, 10.1093/schbul/sbn093.
Robinson, C.L., Fonseca, A.C.G., Diejomaoh, E.M., D'Souza, R.S., Schatman, M.E., Orhurhu, V., et al. Scoping Review: The Role of Psychedelics in the Management of Chronic Pain. J Pain Res 17 (2024), 965–973, 10.2147/JPR.S439348.
F.E. Rosas, P.A.M. Mediano, C. Timmermann, AI. Luppi, D. Candia-Rivera, R. Abbasi-Asl, et al. The entropic heart: Tracking the psychedelic state via heart rate dynamics 2023:2023.11.07.566008. https://doi.org/10.1101/2023.11.07.566008.
Sanz, Aubinet, LRD, Cassol, C., Bodart, H., Wannez, O., Bonin, S., Barra, EACA., Lejeune, N., Martial, C., Chatelle, C., Ledoux, D., Laureys, S., Thibaut, A., Gosseries, O., Seconds administration guidelines: a fast tool to assess consciousness in brain-injured patients. J. Vis. Exp.(168), 2021, e61968, 10.3791/61968.
Sarasso, S., Casali, A.G., Casarotto, S., Rosanova, M., Sinigaglia, C., Massimini, M., Consciousness and complexity: a consilience of evidence. Neurosci. Conscious. 2021 (2021), 1–24, 10.1093/NC/NIAB023.
Schartner, M.M., Carhart-Harris, R.L., Barrett, A.B., Seth, A.K., Muthukumaraswamy, S.D., Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin. Sci. Rep., 7, 2017, 10.1038/srep46421.
Schartner, M., Seth, A., Noirhomme, Q., Boly, M., Bruno, M.A., Laureys, S., et al. Complexity of multi-dimensional spontaneous EEG decreases during propofol induced general anaesthesia. PLoS One, 10, 2015, e0133532, 10.1371/journal.pone.0133532.
Schenberg, E.E., Alexandre, J.F.M., Filev, R., Cravo, A.M., Sato, J.R., Muthukumaraswamy, S.D., et al. Acute Biphasic Effects of Ayahuasca. PLoS One, 10, 2015, e0137202, 10.1371/journal.pone.0137202.
Scott, G., Carhart-Harris, R.L., Psychedelics as a treatment for disorders of consciousness. Neurosci. Conscious. 2019 (2019), 1–8, 10.1093/nc/niz003.
Siegel, J.S., Subramanian, S., Perry, D., Kay, B.P., Gordon, E.M., Laumann, T.O., et al. Psilocybin desynchronizes the human brain. Nature 632 (2024), 131–138, 10.1038/s41586-024-07624-5.
Sinkkonen, J., Tiitinen, H., Näätänen, R., Gabor filters: an informative way for analysing event-related brain activity. J Neurosci Methods 56 (1995), 99–104, 10.1016/0165-0270(94)00111-s.
Tallon-Baudry, C., Bertrand, O., Delpuech, C., Pernier, J., Stimulus Specificity of Phase-Locked and Non-Phase-Locked 40 Hz Visual Responses in Human. J Neurosci 16 (1996), 4240–4249, 10.1523/JNEUROSCI.16-13-04240.1996.
Tewarie, P., Hunt, B.A.E., O'Neill, G.C., Byrne, A., Aquino, K., Bauer, M., et al. Relationships Between Neuronal Oscillatory Amplitude and Dynamic Functional Connectivity. Cereb. Cortex 29 (2019), 2668–2681, 10.1093/cercor/bhy136.
Thibaut, A., Wannez, S., Donneau, A.F., Chatelle, C., Gosseries, O., Bruno, M.A., et al. Controlled clinical trial of repeated prefrontal tDCS in patients with chronic minimally conscious state. Brain Inj. 31 (2017), 466–474, 10.1080/02699052.2016.1274776.
Thibaut, A., Schiff, N., Giacino, J., Laureys, S., Gosseries, O., Therapeutic interventions in patients with prolonged disorders of consciousness. The Lancet Neurology 18 (2019), 600–614, 10.1016/S1474-4422(19)30031-6.
Timmermann, C., Roseman, L., Schartner, M., Milliere, R., Williams, L.T.J., Erritzoe, D., et al. Neural correlates of the DMT experience assessed with multivariate EEG. Sci Rep, 9, 2019, 16324, 10.1038/s41598-019-51974-4.
Timmermann, C., Roseman, L., Haridas, S., Rosas, F.E., Luan, L., Kettner, H., et al. Human brain effects of DMT assessed via EEG-fMRI. Proc. Natl. Acad. Sci., 120, 2023, 10.1073/PNAS.2218949120 e2218949120.
Tylš, F., Páleníček, T., Horáček, J., Psilocybin – Summary of knowledge and new perspectives. Eur. Neuropsychopharmacol. 24 (2014), 342–356, 10.1016/j.euroneuro.2013.12.006.
van der Lande GJM, Manasanch A, Casas-Torremocha D, Dalla Porta L, Gosseries O, Alnagger N, et al. Identification and neuromodulation of brain states to promote recovery of consciousness 2023. https://doi.org/10.5281/zenodo.8377867.
Van Der Walt, J., Parker, R., LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain. S Afr Med J 113 (2023), 22–26, 10.7196/SAMJ.2023.v113i11.814.
Vargas, M.V., Dunlap, L.E., Dong, C., Carter, S.J., Tombari, R.J., Jami, S.A., et al. Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors. Science (New York, N.Y.) 379 (2023), 700–706.
Vejmola, Č., Tylš, F., Piorecká, V., Koudelka, V., Kadeřábek, L., Novák, T., et al. Psilocin, LSD, mescaline, and DOB all induce broadband desynchronization of EEG and disconnection in rats with robust translational validity. Transl Psychiatry 11 (2021), 1–8, 10.1038/s41398-021-01603-4.
Vlisides, P.E., Bel-Bahar, T., Nelson, A., Chilton, K., Smith, E., Janke, E., et al. Subanaesthetic ketamine and altered states of consciousness in humans. Br. J. Anaesth., 2018, 10.1016/j.bja.2018.03.011.
Wannez, S., Gosseries, O., Azzolini, D., Martial, C., Cassol, H., Aubinet, C., et al. Prevalence of coma-recovery scale-revised signs of consciousness in patients in minimally conscious state. Neuropsychol. Rehabil. 2011 (2017), 1–10, 10.1080/09602011.2017.1310656.
Whyte, J., Rajan, R., Rosenbaum, A., Katz, D., Kalmar, K., Seel, R., et al. Zolpidem and restoration of consciousness. Am J Phys Med Rehabil 93 (2014), 101–113, 10.1097/PHM.0000000000000069.
Wsół, A., Cardiovascular safety of psychedelic medicine: current status and future directions. Pharmacol Rep 75 (2023), 1362–1380, 10.1007/s43440-023-00539-4.
